XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning Balances at Dec. 31, 2020 $ 34,189 $ 5 $ 19 $ 452,129 $ (9,933) $ (410,609) $ 2,578
Beginning Balances (in shares) at Dec. 31, 2020   5,000 18,055        
Net income (loss) 1,620         1,620  
Unrealized gain (loss) from foreign currency translation adjustments (629)           (629)
Issuance of common stock in connection with vesting of stock awards 1   $ 1        
Issuance of common stock in connection with vesting of stock awards (shares)     421        
Proceeds from exercise of stock options 299     299      
Proceeds from exercise of stock options     29        
Stock-based compensation 2,606     2,606      
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (1,201)       (1,201)    
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (shares)     (82)        
Issuance of common stock in connection with warrant exercise (shares)     28        
Issuance of common stock in connection with public offering 37,627   $ 4 37,623      
Issuance of common stock in connection with public offering (shares)     3,779        
Ending Balances at Dec. 31, 2021 74,512 $ 5 $ 24 492,657 (11,134) (408,989) 1,949
Ending Balances (in shares) at Dec. 31, 2021   5,000 22,230        
Net income (loss) (392)         (392)  
Unrealized gain (loss) from foreign currency translation adjustments (848)           (848)
Issuance of common stock in connection with vesting of stock awards (shares)     461        
Stock-based compensation 3,161     3,161      
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (1,039)       (1,039)    
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (shares)     (68)        
Ending Balances at Dec. 31, 2022 75,394 $ 5 $ 24 495,818 (12,173) (409,381) 1,101
Ending Balances (in shares) at Dec. 31, 2022   5,000 22,623        
Net income (loss) (5,489)         (5,489)  
Unrealized gain (loss) from foreign currency translation adjustments 228           228
Issuance of common stock in connection with vesting of stock awards 1   $ 1        
Issuance of common stock in connection with vesting of stock awards (shares)     459        
Stock-based compensation 3,971     3,971      
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units $ (796)       (796)    
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (shares)     (110)        
Proceeds from exercise of warrants, shares 275            
Proceeds from exercise of warrants $ 963     963      
Ending Balances at Dec. 31, 2023 $ 74,272 $ 5 $ 25 $ 500,752 $ (12,969) $ (414,870) $ 1,329
Ending Balances (in shares) at Dec. 31, 2023   5,000 23,247